Questions to Ask: Engaging Patients & Sites in Digital Health Trials Posted on June 7, 2021February 13, 2025 by Hannah Faulkner Questions to Ask: Engaging Patients & Sites in Digital Health Trials
Checklist for Sponsors: Considerations in Selecting & Equipping Sites for Clinical Trials with Digital Health Technologies Posted on June 7, 2021February 13, 2025 by Hannah Faulkner Checklist for Sponsors: Considerations in Selecting & Equipping Sites for Clinical Trials with Digital Health Technologies
Checklist for Investigative Sites: Questions to Ask During Budgeting & Contracting Posted on June 7, 2021February 13, 2025 by Hannah Faulkner Checklist for Investigative Sites: Questions to Ask During Budgeting & Contracting
Digital Health Technologies Data Flow Diagram Posted on June 7, 2021February 6, 2025 by Hannah Faulkner Digital Health Technologies Data Flow Diagram
Case Study: Feasibility Testing to Promote Successful Inclusion of Digital Health Technologies for Data Capture Posted on June 7, 2021February 11, 2025 by Hannah Faulkner Case Study: Feasibility Testing to Promote Successful Inclusion of Digital Health Technologies for Data Capture
Case Study: Verification & Validation Processes in Practice Posted on June 7, 2021February 11, 2025 by Hannah Faulkner Case Study: Verification & Validation Processes in Practice
Decision Support Tool: Real-Time Data Sharing with Study Participants Posted on June 7, 2021February 6, 2025 by Hannah Faulkner Decision Support Tool: Real-Time Data Sharing with Study Participants
Framework: Specifications to Consider During Digital Health Technology Selection Posted on June 7, 2021February 11, 2025 by Hannah Faulkner Framework: Specifications to Consider During Digital Health Technology Selection
Recommendations for Registry Trials Posted on June 7, 2021February 11, 2025 by Hannah Faulkner Recommendations for Registry Trials
Figure: Data Processes & Information to Provide to FDA Posted on June 7, 2021February 5, 2025 by Hannah Faulkner Figure: Data Processes & Information to Provide to FDA
